Robert M. Hoffman
Robert M. Hoffman completed his B.A of biology at the State University of New York, Buffalo, New York, and went on to complete his PhD of biology at Harvard University in Cambridge, Massachusetts. Robert has been a faculty member at the University of California San Diego since 1979 and in 1995 became Professor in the Department of Surgery at the University of California San Diego. Since 1984 till now, Robert has been the President, Chairman of Board and CEO at AntiCancer, Inc., located in San Diego, California. Robert has gained a number of significant achievements during his career, to name a few; the first to discover a mutant in energy metabolism, the first to compare the pattern of gene expression in normal and cancer cells, the first to demonstrate that human cancer cells have aberrant DNA methylation, the first to use fluorescent proteins for in vivo imaging, the first to image the tumour microenvironment, co-discovered that blood vessels in tumours can be formed from cancer cells and many more. Robert completed his postdoctoral training at Harvard University, Department of Biology (1971 – 1973), Harvard Medical School, Massachusetts General Hospital (1973 – 1975), the Shemyakin Institute of Bioorganic Chemistry, Moscow, as a USA-USSR National Academy of Sciences Exchange Fellow (1976 – 1977), Weizmann Institute of Science (1978). Since 1986, Robert has been on the following review boards - Ad-Hoc Reviewer and National Cancer Institute, as well as the following editorial boards - Anticancer Research, In Vitro Cellular and Developmental Biology, and Clinical Cancer Research. Robert has published approximately 600 scientific papers and has been presented many honors and awards in his field, along with presenting at many conferences around the world.
Abstracts this author is presenting: